Atlas Trials

Effect of Subanesthetic Dose Esketamine on Propofol-refentanil Closed-loop Targeted Controlled Infusion

Clinical trial NCT05943028 · UNKNOWN

Trial details

NCT number
NCT05943028
Sponsor
bo xu
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Esketamine
Start date
2023-07-01
Primary completion
2024-10-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.